Lanraplenib monosuccinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib monosuccinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM)
Molecular Weight:
561.59
CAS Number:
[1800046-97-2]
Formula:
C27H31N9O5
Target:
Syk
* VAT and and shipping costs not included. Errors and price changes excepted